Ethan Watt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ethan Watt has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Amar Kumar Mohanty
Bioproducts Discovery and Development Centre, Department of Plant Agriculture, Crop Science Building, University of Guelph, 50 Stone Road East, Guelph, Ontario, Canada
1 shared publication Benjamin Maldonado
Bioproducts Discovery and Development Centre, Department of Plant Agriculture, University of Guelph, Guelph, Canada
1 shared publicationDeborah F. Mielewski
Vehicle Research and Technologies, Ford Research and Innovation Laboratory, Ford Motor Company, Dearborn, USA
1 shared publication- Emmanuel Abraham Ho
Laboratory for Drug Delivery and Biomaterials, School of Pharmacy, University of Waterloo, Kitchener, Canada
1 shared publication Ilinca Andriescu
School of Pharmacy, University of Waterloo, Waterloo, ON, N2G 1C5, Canada
1 shared publicationLawrence T. Drzal
Composite Materials and Structures Center, Michigan State University, USA
1 shared publication
Latest Publications
- 16 September 2024
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 15 (5) , 1739-1754
Pneumolysin-responsive liposomal platform for selective treatment of Streptococcus pneumoniae
The bacterium Streptococcus pneumoniae has become a leading cause of meningitis, sepsis, and bacterial pneumonia worldwide, with increased prevalence of antibiotic-resistant serotypes serving to exacerbate the issue. The main factor responsible for colonization and immune response escape in pneumococcal infections is the secreted molecule pneumolysin, which is a subset within a family of related toxins that form transmembrane pores in biological membranes through cholesterol recognition and binding. The conserved activity and structure of pneumolysin between all observed S. pneumoniae serotypes, along with its requirement for pathogenicity, has made this molecule an attractive target for vaccination, diagnostic, and sequestration platforms, but not yet as a facilitative agent for therapeutic treatment. Consequently, the present work aimed to examine the impact of liposomal cholesterol content for pneumolysin-induced release of the encapsulated antimicrobial peptide nisin. It was determined that a cholesterol content above 45 mol% was necessary to facilitate interactions with both purified pneumolysin toxin and S. pneumoniae culture, demonstrated through enhanced nisin release and a reduction in hemolytic rates upon exposure of the toxin with cholesterol-rich vesicles. Antibacterial testing highlighted the ability of the developed platform to elicit a potent and specific bactericidal response in vitro against cultured S. pneumoniae when compared to a control strain, Staphylococcus epidermidis. It further improved viability of a fibroblast cell line upon S. pneumoniae challenge, outperforming free nisin via the synergistic impact of simultaneous bacterial clearance and pneumolysin neutralization. These findings collectively indicate that cholesterol-rich liposomes hold promise as a selective treatment platform against pneumococcal infections.
- 16 September 2024
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 15 (5) , 1739-1754
Pneumolysin-responsive liposomal platform for selective treatment of Streptococcus pneumoniae
The bacterium Streptococcus pneumoniae has become a leading cause of meningitis, sepsis, and bacterial pneumonia worldwide, with increased prevalence of antibiotic-resistant serotypes serving to exacerbate the issue. The main factor responsible for colonization and immune response escape in pneumococcal infections is the secreted molecule pneumolysin, which is a subset within a family of related toxins that form transmembrane pores in biological membranes through cholesterol recognition and binding. The conserved activity and structure of pneumolysin between all observed S. pneumoniae serotypes, along with its requirement for pathogenicity, has made this molecule an attractive target for vaccination, diagnostic, and sequestration platforms, but not yet as a facilitative agent for therapeutic treatment. Consequently, the present work aimed to examine the impact of liposomal cholesterol content for pneumolysin-induced release of the encapsulated antimicrobial peptide nisin. It was determined that a cholesterol content above 45 mol% was necessary to facilitate interactions with both purified pneumolysin toxin and S. pneumoniae culture, demonstrated through enhanced nisin release and a reduction in hemolytic rates upon exposure of the toxin with cholesterol-rich vesicles. Antibacterial testing highlighted the ability of the developed platform to elicit a potent and specific bactericidal response in vitro against cultured S. pneumoniae when compared to a control strain, Staphylococcus epidermidis. It further improved viability of a fibroblast cell line upon S. pneumoniae challenge, outperforming free nisin via the synergistic impact of simultaneous bacterial clearance and pneumolysin neutralization. These findings collectively indicate that cholesterol-rich liposomes hold promise as a selective treatment platform against pneumococcal infections.
- Top Cited PapersOpen Access
- 17 June 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (35) , 21447-21462
Ocean plastics: environmental implications and potential routes for mitigation – a perspective
Ocean plastics are of utmost global concern due to their impact on the environment, society, and economy. This perspective addresses the major contributing sources of ocean plastic pollution, their effects, and promising mitigation strategies.
- 17 June 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (35) , 21447-21462
Top Cited PapersOpen AccessOcean plastics: environmental implications and potential routes for mitigation – a perspective
Ocean plastics are of utmost global concern due to their impact on the environment, society, and economy. This perspective addresses the major contributing sources of ocean plastic pollution, their effects, and promising mitigation strategies.